Organization | NewLink Genetics Inc

NewLink Genetics Inc Report issue

For profit Phase 1 Phase 2 Phase 3

Founded: Ames IA United States (1999)

Organization Overview

First Clinical Trial

2003

NCT00073398

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

NewLink Genetics Corporation | NewLink Genetics Inc | NewLink Genetics Incorporation

Active Ingredients

Drugs in Phase 3 Trials (15)

Key: NewLink Genetics Inc (14) Acquired (1)

algenpantucel-l (2 trials)

capecitabine (xeloda) (1 trial)

docetaxel (taxotere) (3 trials)

fluorouracil (efudex) (4 trials)

gemcitabine (gemzar) (5 trials)

hyperacute-lung cancer vaccine (2 trials)

hyperacute-pancreatic cancer vaccine (4 trials)

indoximod (13 trials)

irinotecan (Camptosar) (2 trials)

leucovorin (3 trials)

nivolumab (opdivo) (3 trials)

oxaliplatin (eloxatin) (3 trials)

paclitaxel (taxol) (4 trials)

pembrolizumab (keytruda) (3 trials)

pemetrexed (alimta) (1 trial)

Drugs in Phase 2 Trials (16)

Key: NewLink Genetics Inc (15) Acquired (1)

alpha (1,3) galactosyltransferase expressing allogeneic tumor cells (1 trial)

bevacizumab (avastin) (3 trials)

camptothecin (1 trial)

crlx301 (1 trial)

cytarabine (cytosar-u) (1 trial)

glucose monohydrate (2 trials)

hyperacute (2 trials)

hyperacute-melanoma vaccine (2 trials)

hyperacute-prostate cancer vaccine (1 trial)

idarubicin (idamycin) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

ipilimumab (yervoy) (2 trials)

it-101 (6 trials)

somatropin (protropin) (3 trials)

temozolomide (temodar) (2 trials)

tergenpumatucel-l (1 trial)

Drugs in Phase 1 Trials (3)

Key: NewLink Genetics Inc (1) Acquired (2)

bpsc-1001 vaccine (4 trials)

gdc-0919 (1 trial)

hyperacute-renal cancer vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 2)

Adenocarcinoma of Lung (Phase 2)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Large Cell (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Ependymoma (Phase 1)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Gliosarcoma (Phase 2)

Hemorrhagic Fever, Ebola (Phase 1)

Kidney Neoplasms (Phase 1)

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lung Neoplasms (Phase 3)

Medulloblastoma (Phase 1)

Melanoma (Phase 3)

Neoplasms (Phase 3)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 3)

Prostatic Neoplasms (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 43
# of Trial APIs: 34